Quratis Inc. (KOSDAQ:348080)
South Korea · Delayed Price · Currency is KRW 1,071.00
+6.00 (0.56%)
At close: Jan 23, 2026
Quratis Revenue
Quratis had revenue of 506.50M KRW in the quarter ending September 30, 2025, with 468.41% growth. This brings the company's revenue in the last twelve months to 2.28B, up 607.99% year-over-year. In the year 2024, Quratis had annual revenue of 373.80M, down -63.71%.
Revenue (ttm)
2.28B
Revenue Growth
+607.99%
P/S Ratio
38.61
Revenue / Employee
n/a
Employees
n/a
Market Cap
88.00B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 373.80M | -656.26M | -63.71% |
| Dec 31, 2023 | 1.03B | -6.49B | -86.31% |
| Dec 31, 2022 | 7.52B | 5.94B | 373.65% |
| Dec 31, 2021 | 1.59B | 1.48B | 1,344.13% |
| Dec 31, 2020 | 110.00M | 30.00M | 37.50% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| CTCBIO | 132.76B |
| Cell Biotech | 50.65B |
| Choong Ang Vaccine Laboratory | 39.19B |
| Naturalendo Tech | 21.87B |
| Ark Solutions | 21.50B |
| PanGen Biotech | 15.27B |
| HLB Pep | 4.89B |
| Progen | 450.00M |